Vimarsana
Biggest News Aggregation in the World

Page 2 - Ilan Danieli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ilan Danieli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ilan Danieli Today - Breaking & Trending Today

Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript - Vimarsana News

Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript

Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript August 17, 2023 Precipio, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1. Operator: Welcome to the Precipio Second Quarter 2023 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being recorded. Statements made during […]

Source: yahoo.com
Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of - Vimarsana News

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of

Panel-Based Approach of Driver Mutation Detection Proves Crucial for Patient Care...

Precipio, Inc. (NASDAQ:PRPO) Q1 2023 Earnings Call Transcript - Vimarsana News

Precipio, Inc. (NASDAQ:PRPO) Q1 2023 Earnings Call Transcript

Operator: Welcome to the Precipio Q1 2023 Shareholder Update Conference Call. All participants will be in listen-only mode. Please note that the conference is being recorded.

Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division - Vimarsana News

Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division

04.05.2023 - Customer’s pathology services annual revenues expected to exceed $1.5MNEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces another agreement with a new pathology services ...

Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined - Vimarsana News

Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined

19.04.2023 - Q1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022NEW HAVEN, Conn., April 19, 2023 (GLOBE NEWSWIRE) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that Q1-2023 product ...